Topical treatment regimens in male androgenetic alopecia
Not Applicable
Completed
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2020/05/025390
- Lead Sponsor
- ady Hardinge Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. All new male patients with clinically diagnosed androgenetic alopecia of grade III or higher (Modified Norwood Hamilton classification)
Exclusion Criteria
1. Patients who have used any topical or systemic drugs in the past 6 months to promote hair growth
2. Patients with other scalp diseases that affect hair growth including seborrheic capitis
3. Patients with elevated levels of serum prostate specific antigen (PSA)
4. Patients with thyroid abnormality or vitamin D deficiency
5. Patients with history of continuing intake of following drugs â?? antihypertensives, antiepileptics, cytotoxic drugs, systemic corticosteroids, bronchodilators and vasodilators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method